Cargando…
Perioperative factors predicting delayed enteral resumption and hospital length of stay in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Retrospective cohort analysis from a single centre in India
BACKGROUND AND AIMS: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an extensive procedure associated with significant morbidity, delay in return of gastrointestinal function and discharge from hospital. Our aim was to assess perioperative factors influencing ent...
Autores principales: | Balakrishnan, Kalpana, Srinivasaraghavan, Nivedhyaa, Venketeswaran, Meenakshi V, Ramasamy, Thendral, Seshadri, Ramakrishnan A, Raj, E Hemanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852446/ https://www.ncbi.nlm.nih.gov/pubmed/33542565 http://dx.doi.org/10.4103/ija.IJA_480_20 |
Ejemplares similares
-
Intubation outcomes using the aerosol box during the COVID-19 pandemic: A prospective, observational study
por: Venketeswaran, Meenakshi V, et al.
Publicado: (2021) -
Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
por: Solanki, Sohan Lal, et al.
Publicado: (2019) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014) -
Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis
por: Balakrishnan, Kalpana P, et al.
Publicado: (2018) -
Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)